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Epidermal growth factor receptor (EGFR) activation by GPCRs regulates many important biological processes. ADAM
metalloprotease activity has been implicated as a key step in transactivation, yet the regulatory mechanisms are not fully
understood. Here, we investigate the regulation of transforming growth factor- (TGF-) shedding by reactive oxygen
species (ROS) through the ATP-dependent activation of the P2Y family of GPCRs. We report that ATP stimulates TGF-
proteolysis with concomitant EGFR activation and that this process requires TACE/ADAM17 activity in both murine
fibroblasts and CHO cells. ATP-induced TGF- shedding required calcium and was independent of Src family kinases
and PKC and MAPK signaling. Moreover, ATP-induced TGF- shedding was completely inhibited by scavengers of ROS,
whereas calcium-stimulated shedding was partially inhibited by ROS scavenging. Hydrogen peroxide restored TGF-
shedding after calcium chelation. Importantly, we also found that ATP-induced shedding was independent of the
cytoplasmic NADPH oxidase complex. Instead, mitochondrial ROS production increased in response to ATP and
mitochondrial oxidative complex activity was required to activate TACE-dependent shedding. These results reveal an
essential role for mitochondrial ROS in regulating GPCR-induced growth factor shedding.
INTRODUCTION
Epidermal growth factor receptor (EGFR) has long been
recognized as a critical component of cellular signal trans-
duction machinery (Holbro and Hynes, 2004). The discovery
of the essential role of EGFR in propagating signals gener-
ated by G-protein–coupled receptor (GPCR) agonists indi-
cates that EGFR may function as a central signal integration
point for stimuli impacting the cell surface (Blobel, 2005;
Ohtsu et al., 2006). A wide variety of GPCR agonists, includ-
ing lysophosphatidic acid, phenylephrine, and carbachol,
can harness EGFR to promote ERK activation, leading to
physiological and pathophysiological responses (Yan et al.,
2002; Gschwind et al., 2003; Schafer et al., 2004b; Zhang et al.,
2004). GPCR cross-talk was previously thought to consist of
entirely intracellular signaling pathways that led to EGFR
phosphorylation, independent of ligand binding and dimer-
ization. However, elucidation of a rapid, metalloprotease-
dependent growth factor cleavage step leading to EGFR
activation (Prenzel et al., 1999) revealed the importance of
regulated proteolysis in GPCR-EGFR transactivation. More
recent studies have shown the in vivo importance of this
phenomenon (Zhang et al., 2004; Lautrette et al., 2005).
The seven members of the EGF family of growth factors,
amphiregulin (AR), betacellulin, EGF, epigen, epiregulin,
heparin-binding EGF (HB-EGF), and transforming growth
factor alpha (TGF-), are all initially synthesized as type-I
transmembrane precursors, containing the growth factor
moiety in the ectodomain (Lee et al., 2003). Several studies
have demonstrated the biological activity of the noncleav-
able, membrane-anchored precursor molecules (Brachmann
et al., 1989; Wong et al., 1989), but the metalloprotease de-
pendence of transactivation, the loss of EGFR signaling in
cells treated with metalloprotease inhibitors (Dong et al.,
1999; Borrell-Pages et al., 2003), and the convergence of
phenotypes of growth factor and protease knockout models
indicate that proteolytic cleavage of the growth factors is an
important and regulatable step in most contexts (Peschon et
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al., 1998; Iwamoto et al., 2003; Jackson et al., 2003; Sternlicht
et al., 2005).
A variety of in vitro and in vivo evidence points to the
ADAM family member tumor necrosis factor alpha–con-
verting enzyme (TACE/ADAM17) as the critical convertase
for TGF-, AR, and HB-EGF. ADAMs (a disintegrin and
metalloprotease), along with matrix metalloproteases, be-
long to the metzincin family of zinc-dependent proteases
(Blobel, 2005). When mice lacking active TACE were com-
pared with TGF-, AR, and HB-EGF knockouts, they were
found to share epithelial defects with homozygous TGF-
null mice (Peschon et al., 1998), loss of mammary gland
branching as in mice lacking AR (Sternlicht et al., 2005), and
heart and lung defects with HB-EGF/ animals (Iwamoto
et al., 2003; Jackson et al., 2003). Fibroblasts derived from the
TACE-deficient mice were impaired in shedding of TGF-,
HB-EGF, and AR, but shedding could be rescued by trans-
fection of wild-type TACE into the cells (Sunnarborg et al.,
2002). TACE also cleaved each growth factor in vitro at the
physiologically relevant site (Sunnarborg et al., 2002; Hinkle
et al., 2004). In cell culture, knockdown of TACE expression
can also have an inhibitory effect on growth factor–depen-
dent transactivation by lysophosphatidic acid, angiotensin
II, and epoxyeicosatrienoic acid stimulation (Schafer et al.,
2004b; Mifune et al., 2005; Chen et al., 2007). The overlapping
phenotypes of mice lacking these growth factors and those
lacking TACE/ADAM17, along with the in vitro results,
support a critical role for the soluble forms of the growth
factors and highlight the importance of their proteolysis as a
regulatory event.
Despite its presence at a critical signaling juncture, the
regulation of ADAM metalloprotease activity is still not
fully understood. ADAMs are type I transmembrane pro-
teins that possess an archetypal organization, including the
metalloprotease and disintegrin domains, along with a cy-
toplasmic domain often rich in SH3-binding sites that could
potentially regulate ADAM inside-out signaling (Seals and
Courtneidge, 2003; Blobel, 2005). Several signaling compo-
nents have been implicated in GPCR-initiated TACE activa-
tion. Src-like nonreceptor tyrosine kinases have long been
accepted as intermediates in EGFR transactivation and have
been found in association with several ADAMs leading to
phosphorylation (Pierce et al., 2001; Seals and Courtneidge,
2003; Luttrell and Luttrell, 2004; Zhang et al., 2006). Elevation
of intracellular calcium was also found to stimulate the
release of ErbB ligands in an ADAM-dependent manner
(Mifune et al., 2005; Sanderson et al., 2005; Horiuchi et al.,
2007), whereas protein kinase C (PKC) has long been sus-
pected to play a role in ADAM activation because of the
ability of phorbol 12-myristate 13-acetate (PMA) to trigger
PKC signaling and to stimulate ectodomain shedding. Mi-
togen-activated protein kinase (MAPK) proteins have also
been implicated both prior and subsequent to EGFR activa-
tion (Prenzel et al., 1999; Umata et al., 2001; Gschwind et al.,
2003; Fischer et al., 2004). Lastly, reactive oxygen species
(ROS) can function as second messengers in response to
G-protein signaling (Zhang et al., 2001; Cross and Temple-
ton, 2006). ROS have been shown to be necessary for angio-
tensin II- and endothelin-1–mediated TACE activation and
HB-EGF shedding, possibly through direct modification of a
cysteine that coordinates the binding of the inhibitory
prodomain (Zhang et al., 2001; Mifune et al., 2005; Chen et al.,
2006). The wide variety of possible regulatory mechanisms
suggests substrate- or cell type-specific pathways dependent
on the stimulant or intended signal effect.
In this study we characterize a ROS-mediated pathway
wherein ATP initiates P2Y signaling, stimulating TACE-
dependent TGF- proteolysis and EGFR phosphorylation.
TGF- shedding is independent of Src, PKC, and MAPK
signaling. We report for the first time the requirement for
mitochondrially derived ROS, whose production is stimu-
lated by ATP, for regulation of GPCR-induced growth factor
shedding. Collectively, these results offer a model that can be
utilized to further our understanding of the regulatory mech-
anisms of TACE-dependent cell surface proteolysis.
MATERIALS AND METHODS
Materials
RC-20 anti-phosphotyrosine antibody, anti-Shc, and anti-flotillin were pur-
chased from BD Transduction Laboratories (San Jose, CA) and anti-phospho-
tyrosine-EGFR 1068 antibody and anti-EGFR 2232 antibody from Cell Signal-
ing Technology (Danvers, MA). Anti-human TGF- (MF9) was purchased
from Neomarkers (Fremont, CA) and anti-TACE from Exalpha Biologicals
(Shirley, MA). Horseradish peroxidase–conjugated secondary antibodies and
ATPS were from Roche Molecular Biochemicals (Indianapolis, IN). Adeno-
sine and uridine triphosphate were purchased from GE Healthcare (Wauke-
sha, WI). EGF was from Harlan Bioproducts (Indianapolis, IN) and TAPI-2
from Peptides International (Louisville, KY). N-Acetyl-l-cysteine, rotenone
(NAC), myxothiazol, and AG1478 were from Sigma (St. Louis, MO) and all
other chemicals were from Calbiochem (La Jolla, CA).
Cell Lines, Transfections, and Stable Clones
EC-4 (Tace/) and EC-2 (TaceZn/Zn) fibroblasts, provided by Amgen
(Thousand Oaks, CA; Reddy et al., 2000), and their derivatives were main-
tained in DMEM/F-12, 1% FBS with antibiotic. Wild-type and M2 Chinese
hamster ovary (CHO) cells and their derivatives were maintained in DMEM,
10% FBS, 1 nonessential amino acids and antibiotic. HL-60 cells were
maintained in RPMI media, 10% FBS with antibiotic. Plasmid transfections
were performed using LipofectAMINE (Invitrogen, Carlsbad, CA). The hu-
man EGFR cDNA (Saxon and Lee, 1999) was subcloned into modified pCEP4
(Invitrogen) and stably expressed in all indicated cell lines after selection with
800 g/ml hygromycin B (Roche). Alkaline phosphatase–tagged TGF- (To-
kumaru et al., 2000) was kindly sent by Dr. Carl Blobel (Hospital for Special
Surgery, New York, NY). Stable expression of AP-TGF- in wild-type CHO
cells was achieved by selecting clones in 500 g/ml G418 (Sigma). For stable
expression in M2 cells that had already been subjected to G418 selection,
AP-TGF- was subcloned into pcDNA 3.1 hygromycin B vector (Invitrogen)
using a PCR-generated fragment (HindIII-capped forward PCR primer
5-AAGCTTGTTCTAGCGGCACCGC-3; KpnI-capped reverse PCR primer
5-GGTACCCGTTCTTACAGCAAAAGGC-3) and the TOPO cloning kit (In-
vitrogen). Stable clones were selected in 800 g/ml hygromycin B. For stable
expression of pcDNA3 mouse TACE, transfected EC-2 and M2 CHO cells
were selected in 100 g/ml Zeocin (Reddy et al., 2000).
RNA Interference
Small interfering RNA (siRNA) duplexes against mouse TACE (5GG-
GAUUCCUUUCAGCAUUCUUGUCCA-3) from Invitrogen were transiently
transfected into EC-4 EGFR cells by adding 6 l RNAiMAX (Invitrogen) to
100 nM siRNA per 35-mm plate according to the manufacturer’s instructions.
A fluorescent-tagged scrambled sequence was used as a control. Cells were
harvested 48 h after transfection as described below.
Harvesting, Immunoprecipitation, and Western Blot
Analysis
Confluent cells were washed twice in serum-free medium (SFM) and then
starved for 4 h at 37°C in SFM. After a 5-min stimulation, conditioned
medium was collected, and cells were washed in phosphate-buffered saline
(PBS) and lysed in 1% Triton X-100, 50 mM Tris, pH 7.4, 150 mM NaCl with
10 g/ml leupeptin, 20 g/ml aprotinin, 1 mM phenylmethylsulfonyl fluo-
ride, 2 M sodium orthovanadate, 10 mM sodium fluoride, and 5 mM sodium
molybdate (lysis buffer). Protein concentration was determined with a BCA
assay kit (Pierce, Rockford, IL). For some experiments media were concen-
trated using Sep-Pak C-18 reverse-phase cartridges (Waters, Milford, MA;
Sandgren et al., 1990), and TGF- in both lysates and media was measured
with a specific radioimmunoassay (RIA; Russell et al., 1993). For immunopre-
cipitations, equal amounts of protein were incubated for 60 min with primary
antibody at 4°C followed by protein G agarose (Invitrogen) at 4°C for 1 h.
Beads were washed in 20 mM Tris, pH 7.5, 0.1 M NaCl, 0.1 mM EDTA, and
0.1% Nonidet P-40, separated by SDS-PAGE, and transferred to Immobilon
polyvinylidene difluoride (Millipore, Billerica, MA). Membranes were
blocked in Tris-buffered saline, 0.1% Tween 20, and 3% BSA or 5% nonfat dry
milk. Bands were visualized using Pierce SuperSignal West Pico chemilumi-
nescent system for autoradiography.
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Expression of P2Y Receptors by RT-PCR
RNA was extracted from wild-type EC-4 or CHO cells grown in 10-cm dishes
using RNeasy Mini Kit (Qiagen, Valencia, CA). RNA was isolated from fresh
jejunum tissue with Trizol (Invitrogen) according to the manufacturer’s protocol
(Troyer et al., 2001). Total RNA was used to prepare cDNA with MMTV Reverse
Transcriptase (Invitrogen). PCR amplification used primers for mouse P2Y2 or
P2Y4, corresponding to analogous regions to yield the same size products and
species-specific primers for -actin as a loading control. Primers for P2Y2, 5-
ACGGTGCTCTGCAAGCTGGTGC-3; 5-GTAGAGGGTGCGCGTGACGTGG-
3; P2Y4, 5-TACTACTATGCTGCCAGAAACCAC-3; 5-AGCAAAGACAGT-
CAGCACCACAGC-3; mouse -actin, 5-GACAACGGATCCGGCATGTG C-3;
5-GCGGCAGTGGCC ATCTCCTGC-3; and hamster -actin, 5-ACTCCTACG-
TGGGTGACGAG-3; 5-AAGGAAGGCTGGAAAAGAGC-3.
Inositol Phosphate Incorporation
EC-4 cells were seeded into 24-well plates and cultured overnight. The next
day, [3H]myo-inositol was added at 0.4 Ci/well and incubated overnight.
Cells were stimulated for 15 min with vehicle, 100 M ATP or 100 M UTP
as indicated, and [3H]inositol incorporation was assayed as previously de-
scribed (Hoffmann et al., 1999).
Alkaline Phosphatase Assay
Cells were plated in 24-well dishes at a density of 2.5  105 per well for 18 h.
Cells were washed twice in SFM and starved in fresh SFM for 4 h at 37°C.
Vehicle (DMSO or water) or inhibitors were added directly to cells for 30 min.
After inhibition, media were changed to fresh SFM containing inhibitor and
agonist for 5 min. Media were then collected and centrifuged for 30 min at
14,000  g at 4°C. Media aliquots were mixed with an equal volume of 2 AP
buffer (100 mM glycine, pH 10.4, 1 mM MgCl2, 1 mM ZnCl2, and 5.4 mM
p-nitrophenylphosphate; Sahin et al., 2006) and allowed to develop at room
temperature. Absorbance at 405 nm was measured to quantify alkaline phos-
phatase (AP) activity. To test for possible interference in alkaline phosphatase
activity by signaling inhibitors, conditioned media from 150-mm dishes of
vehicle or 100 M ATP-stimulated CHO-APT cells were divided after har-
vesting from cells for treatment with the appropriate concentration of each
reagent.
Exosome Purification
Exosomes were purified from conditioned media by differential centrifuga-
tion, as previously described (Thery et al., 2006). In short, 8  107 cells were
serum-starved for 4 h and then pretreated with vehicle or 20 M TAPI-2 for
30 min. In fresh SFM, cells were stimulated with vehicle or 100 M ATP for
5 min, and the media were collected and pooled. To remove live, whole cells
the media were subjected to centrifugation at 300  g for 10 min. An aliquot
of supernatant along with the entire pellet, which was collected in lysis buffer,
were stored at 80°C. The remaining supernatant was centrifuged again at
2000  g for 10 min to separate dead cells and 10,000  g for 30 min to remove
cell debris. Aliquots were again collected for analysis. Finally, exosomes were
pelleted by centrifugation at 100,000  g for 60 min. The lysed pellets were
prepared for Western blot analysis, and the media aliquots were split and
prepared for Western blot analysis and AP assays.
Cell Viability
An equal number of cells was plated in duplicate, 24 h before treatment for
each condition. Cells were then serum-starved for 4 h before treatment with
the appropriate concentration of reagent for 30 min. After that, cells were
washed twice in PBS and then trypsinized and collected. Viable cells were
counted on a hemacytometer, and total cells per plate were compared with
vehicle-treated cells to determine the effect of each reagent on cell number.
Measurement of Membrane NADPH Activity
CHO or HL-60 cells (1.5  108) were stimulated with vehicle, 100 M ATP, or
20 M PMA for 5 min at 37°C. Media were removed, and cells washed twice
in ice-cold PBS. Intact cells were collected from the plates in PBS. Plasma
membranes were isolated using the Membrane Protein Extraction Kit as
directed by manufacturer (BioVision, Mountain View, CA). Protein concen-
trations were determined, and 2 g of protein was used to measure SOD
inhibitable superoxide production by cytochrome C reduction in vitro
(Teufelhofer et al., 2003; Dikalov et al., 2007). Briefly, 100 M cytochrome C
and 100 M NADPH with or without 100 U/ml SOD were prepared in HBSS
and mixed with plasma membrane proteins in an equal volume in a 96-well
plate and incubated at 37°C for the length of the assay. Triplicate samples
were assayed. Absorbance at 540, 550, and 560 nm was measured in a
SpectraMAX platereader (Molecular Devices, Sunnyvale, CA). The difference
in absorbance of 550 nm and the average of 540 and 560 nm was calculated for
each well. The average background absorbance (reaction solution without
protein) was then subtracted and the difference in SOD-treated and untreated
samples was determined. This value was then converted to picomoles of
reduced cytochrome C using the extinction coefficient 21.1 mM1 cm1.
Measurement of Mitochondrial ROS
Mouse cells were plated in 24-well dishes at a density of 2.5  105/well and
cultured for 18 h. Cells were washed twice in SFM and starved in fresh SFM
for 4 h at 37°C. Cells were loaded with 250 nM CM-H2XRos MitoTracker Red
(MTR; Molecular Probes, Eugene, OR) for 15 min at 37°C away from direct
light. Media were aspirated, and cells were washed twice in phenol-free, SFM
supplemented with 2 mM l-glutamine and left in washing media. Cells were
then stimulated for 5 min and excited at 544 nm, and emission was detected
at 612 nm on the fluorescent platereader SpectraMax Gemini XS (Molecular
Devices). Data are presented as a box-and-whisker plot to exhibit the full
range of data points.
Statistical Analysis
The nonparametric Wilcoxon rank-sum test was used for two-group compar-
isons. p  0.05 was considered statistically significant. Statistical analyses
were performed using Prism 5.0 from GraphPad Software (San Diego, CA)
and SAS statistical software (version 9.1, SAS Institute, Cary, NC).
RESULTS
To study the regulation of growth factor cleavage induced
by GPCR stimulation, we chose TACE/ADAM17 cleavage
of proTGF- as a model system. Stimulation of EC-4–trans-
formed fibroblasts that stably express EGFR (EC-4 EGFR;
Figure 1A, bottom panel) with the purinergic receptor ago-
nist ATP led to the phosphorylation of EGFR, as did treat-
ment with exogenous EGF (Figure 1A). ATP transactivation
was also able to stimulate phosphorylation of Shc, an adap-
tor molecule for EGFR (Figure 1B). ATP-induced Shc phos-
phorylation was dependent on EGFR activity as the EGFR-
kinase inhibitor AG1478 was able to block both ATP- and
EGF-stimulated Shc activation. Therefore, these cells possess
the endogenous components to accomplish GPCR-induced
EGFR transactivation and downstream signaling.
Because EC-4 cells constitutively release low levels of
TGF- (Sunnarborg et al., 2002) and fibroblasts often express
P2Y receptors, we asked if ATP stimulation would lead to
rapid release of soluble TGF-. ATP stimulates P2Y2 puri-
nergic receptors with an EC50 of 25 M and the maximal
response at 100 M (Soltoff et al., 1998). Using a highly
specific, TGF- RIA (Russell et al., 1993), we detected a
greater than twofold increase in endogenous TGF- shed-
ding 5 min after addition of 100 M ATP (Figure 1C). The
effect of ATP was not dependent on hydrolysis, as indicated
by comparable results with the noncleavable ATP analog,
ATPS. These results indicate that GPCR stimulation via
purinergic receptors leads to rapid release of soluble TGF-,
and EGFR transactivation.
We also wanted to identify the purinergic receptor sub-
type responsible for this shedding event. Purinergic recep-
tors are classified on the basis of their agonist profile. ATP
can stimulate members of the P2X and P2Y family of recep-
tors. UTP, in contrast, stimulates only P2Y receptors, and
murine P2Y2 and P2Y4 receptors are equipotently activated
by ATP and UTP (Abbracchio et al., 2006). In mouse EC-4
cells, as shown in Figure 1C, UTP stimulates TGF- shedding
at levels similar to that of ATP, indicating use of P2Y receptors.
ATP and UTP also stimulated comparable [3H]inositol incor-
poration in these cells (Supplemental Figure S1). Semiquanti-
tative reverse transcriptase-PCR on RNA from EC-4 mouse
fibroblasts revealed expression of only the P2Y2 receptor sub-
type. P2Y4 receptor was not visible at this low cycle number
but was visible in the positive control jejunum tissue sample
(Figure 1D). These results, together with the ability of ATP and
UTP to stimulate GPCR signaling and TGF- shedding, iden-
tify P2Y2 as the critical receptor.
The paradigm for GPCR-induced EGFR transactivation
requires a metalloprotease-dependent growth factor cleav-
age step (Prenzel et al., 1999). We verified the dependence on
T. J. Myers et al.
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metalloprotease activity in this model system by treating
cells with the hydroxamate compound TAPI-2. In the pres-
ence of this inhibitor, ATP transactivation of EGFR was
abolished, whereas EGF still activated the receptor (Figure
2A). Therefore, purinergic stimulation of EGFR requires
metalloprotease activity.
In astrocytoma cells, ATP stimulated the release of amy-
loid precursor protein through P2Y2 receptors by activating
both ADAM10 and TACE (Camden et al., 2005). In our
system, ATP stimulated TGF- release, and as proTGF- is
preferentially cleaved by TACE over ADAM10 (Le Gall et al.,
2009), we hypothesized that TACE was responsible for the
ATP-induced TGF- release and EGFR transactivation that
we have observed. To test this hypothesis, we performed
siRNA experiments to knock down endogenous TACE in
EC-4 EGFR cells. In control transfected cells, both EGF and
ATP stimulated phosphorylation of EGFR, whereas in the
absence of TACE, ATP-dependent phosphorylation of EGFR
was significantly decreased (Figure 2B). These results were
confirmed in TACE-deficient EC-2 mouse fibroblasts, which
are the complementary cells to wild-type EC-4 cells (Reddy
et al., 2000), stably expressing EGFR. Although EGF acti-
vated its receptor in wild-type and TACE-deficient cells,
ATP was unable to stimulate transactivation of EGFR in the
EC-2 cells compared with the wild-type EC-4 cells (Figure
2C). Similar to our previous observations for constitutive
shedding (Sunnarborg et al., 2002), induction of TGF- re-
lease by treatment with 100 M ATP was abolished in the
absence of TACE (Figure 2D). RIA measurements of un-
stimulated cell lysate indicated comparable TGF- levels in
EC-4 and EC-2 cells. We were also able to restore ATP-
induced shedding in EC-2 cells by stably expressing mouse
TACE (Figure 2E). Thus, we conclude that TACE is the
crucial protease responsible for ATP-induced EGFR transac-
tivation and TGF- shedding in mouse fibroblasts, though
TGF- may not be exclusively responsible for ATP-induced
EGFR activation in this system.
Further investigation into the regulation of TGF- shed-
ding required an assay system with high-throughput capa-
bilities. Alkaline phosphatase-tagged EGF-like growth fac-
tors are an established method of monitoring growth factor
cleavage by quantifying AP activity in conditioned media
(Tokumaru et al., 2000; Sahin et al., 2004; Tanaka et al., 2004;
Horiuchi et al., 2007). To facilitate transfection and culturing,
we shifted our cell model to CHO cells, which have been
used previously to study the regulation of growth factor
shedding (Teixido et al., 1990; Gechtman et al., 1999). Al-
though lacking endogenous EGF-family growth factors,
CHO cells express TACE (Borroto et al., 2003; Li and Fan,
2004) and have been reported to respond to purinergic stim-
ulation (Iredale and Hill, 1993). RT-PCR of CHO RNA re-
vealed strong expression of P2Y2, although P2Y4 was unde-
tectable even with elevated cycle numbers (Figure 3A and
data not shown). Thus, CHO cells should provide a suitable
model for further study of GPCR-induced TGF- shedding.
To test the cells and assay system, we prepared wild-type
CHO clones that stably express AP-tagged TGF- (AP-
Figure 1. GPCR stimulation induces EGFR transactivation and
TGF- shedding. Cells were serum-starved for 4 h. Results are
representative of three separate experiments. (A) Cells were stimu-
lated with vehicle, 20 ng/ml EGF, or 100 M ATP for 5 min.
Phosphorylated EGFR (top) was detected in cell lysates by immu-
noblotting followed by stripping and detection of total EGFR (bot-
tom). (B) EC-4 EGFR cells were inhibited with vehicle or 20 M
AG1478 for 30 min and then stimulated with vehicle, 20 ng/ml EGF,
or 100 M ATP for 5 min. Cell lysates were subjected to anti-Shc
immunoprecipitation followed by immunoblotting for phosphoty-
rosine (top, RC-20) and total Shc protein (bottom). (C) EC-4 cells were
stimulated for 5 min with vehicle, 100 M ATP, 100 M ATPS, or 100
M UTP. Media and lysates were harvested and concentrated as
described in Materials and Methods and analyzed for TGF- content
by specific RIA. Data are presented as the average amount of TGF- in
conditioned media per milligram of total lysate protein from
three separate experiments with at least three replicates. *p 
0.02 compared with the control. (D) Total RNA from EC-4 mouse
fibroblast cells (Fb) or mouse jejunum tissue (Jej) was subjected to first
strand cDNA synthesis with or without reverse transcriptase (RT) and
amplified for 28 cycles to detect the expression of P2Y2 (top) and P2Y4
(middle) receptors. -actin was used a loading control (bottom).
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TGF-) or empty vector (Tokumaru et al., 2000). We next
determined the effect of ATP on AP-TGF- shedding. Anal-
ogous to our results in mouse cells, a 5-min stimulation with
100 M ATP caused a significant increase of AP activity in
the media compared with mock stimulation (Figure 3B).
Likewise, 100 M UTP was able to stimulate a strong TGF-
shedding response in CHO cells. Metalloprotease depen-
dence was verified for ATP- and UTP-induced shedding by
pretreatment of the cells with TAPI-2. When these cells were
stimulated with water, ATP, or UTP, shedding was almost
completely abrogated (Figure 3B). We next confirmed that
TACE was responsible for AP-TGF- shedding in CHO cells
by using CHO M2 cells that carry inactivating mutations in
each endogenous TACE allele (Arribas and Massagué, 1995;
Li and Fan, 2004). After ATP treatment, induction of AP
activity was negligible in M2-AP-TGF- cells stably ex-
pressing AP-TGF-, compared with vehicle-treated cells
(Figure 3C). When TACE was stably expressed in these
cells, constitutive shedding remained low, whereas ATP-
induced shedding was partially recovered. These results
confirm the presence of a P2Y2-TACE-TGF- pathway in
CHO cells.
Figure 2. The metalloprotease TACE/
ADAM17 is required for P2Y-stimulated
TGF- shedding and EGFR transactivation.
(A) EC-4 EGFR cells were serum-starved for
4 h and pretreated with vehicle or 20 M
TAPI-2 for 30 min as indicated. Cells were
then stimulated with vehicle, 20 ng/ml EGF,
or 100 M ATP for 5 min. Phosphorylated
EGFR (top) was detected in cell lysates by
immunoblotting followed by stripping and
detection of total EGFR (bottom). Represen-
tative results of three separate experiments
are shown. (B) EC-4 EGFR cells were tran-
siently transfected with 100 nM siRNA tar-
geting TACE or a scrambled control (Scr).
Forty-eight hours after transfection, cells
were serum-starved and harvested as de-
scribed above. Phosphorylated EGFR (top)
was detected in cell lysates by immunoblot-
ting followed by stripping and detection of
total EGFR (middle) and TACE expression
(bottom). Representative results of three sep-
arate experiments are shown. (C) EC-4 EGFR
or EC-2 (TaceZn/Zn) EGFR cells were se-
rum-starved and harvested as previously de-
scribed. Phosphorylated EGFR (top) was de-
tected in cell lysates by immunoblotting
followed by stripping and detection of total
EGFR (bottom). Representative results of
three separate experiments are shown. (D)
EC-4 and EC-2 cells or (E) EC-2 and EC-2
cells stably expressing transfected mouse
TACE (bottom) were serum-starved for 4 h
and then stimulated for 5 min with vehicle or
100 M ATP. Media and lysates were har-
vested and concentrated as described in Ma-
terials and Methods, and analyzed for TGF-
content by specific RIA. Data are presented
as picograms of TGF- in conditioned media per milligram of total lysate protein from three separate experiments with at least three
replicates. *p  0.05 compared with the control; #p  0.05 compared with ATP.
Figure 3. CHO cells demonstrate P2Y2-TACE-
TGF- shedding. (A) Total RNA from CHO cells
was subjected to first strand cDNA synthesis with or
without reverse transcriptase (RT) and amplified for
28 cycles to detect the expression of P2Y2 (top) and
P2Y4 (middle) receptors. -Actin was used as a load-
ing control (bottom). (B) CHO AP-TGF- cells were
pretreated with vehicle or 20 M TAPI-2 for 30 min.
Cells were then stimulated for 5 min with vehicle,
100 M ATP, or 100 M UTP. Media were collected
and analyzed for alkaline phosphatase (AP) activity.
(C) Mutant M2 CHO AP-TGF- clones, which lack
functional endogenous TACE, or TACE M2 CHO
AP-TGF- clones, which stably express mouse TACE (bottom), were serum-starved for 4 h. Cells were then stimulated for 5 min with vehicle
or 100 M ATP. Media were collected and analyzed for AP activity. AP assay results are an average of three separate experiments with at
least three replicates and are presented relative to the unstimulated control. *p  0.05 compared with control; #p  0.05 compared with
uninhibited stimulation.
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We wanted to confirm that the TGF- and AP activity we
detected in conditioned media resulted from proteolytic
cleavage and not a protease-independent secretory event
such as exosome release (Stoeck et al., 2006). We therefore
isolated exosomes from ATP-stimulated CHO AP-TGF-–
conditioned medium and examined TGF- levels in this
fraction. In ATP-treated cells, AP-TGF- was detected in
supernatants of conditioned media after depletion of each
membrane fraction (Supplemental Figure S2A, top panel),
including exosomes. The AP activity in conditioned media
nonetheless remained strong in the membrane-depleted
fractions (Supplemental Figure S2B). AP-TGF- was also
detected in each of the ATP-stimulated membrane fractions
(Supplemental Figure S2A, middle panel) including in exo-
somes as identified by the marker, flotillin (Supplemental
Figure S2A, bottom panel). TAPI-2 treatment was able to
block release of AP-TGF- in each case. A small loss of signal
at each stage was observed, which likely corresponds to the
membrane bound AP-TGF- removed from the media by
removal of the membrane fractions. These results demon-
strate that after ATP stimulation the majority of TGF- re-
leased from cells is cleaved and not secreted in membranes.
To determine potential regulatory steps of TACE-depen-
dent ATP-induced TGF- shedding, we used chemical in-
hibitors to ask which pathways contributed to the release of
TGF- after ATP stimulation in CHO AP-TGF- cells. Cal-
cium signaling has been implicated in shedding and EGFR
transactivation (Mifune et al., 2005; Horiuchi et al., 2007) and
is also a common signaling component of ATP-induced
purinergic pathways (Abbracchio et al., 2006); therefore, we
wanted to test the effect of calcium on TGF- shedding in
our cell model. Treatment with the calcium specific chelator
BAPTA-AM significantly inhibited ATP-dependent TGF-
shedding (Figure 4). We therefore tested whether calcium
influx stimulated shedding with a nontoxic concentration of
calcium ionophore A23187 (1 M, Supplemental Table S1),
which led to a significant increase in shedding over control
levels, comparable to ATP (Figure 5A). A23187-induced
shedding was TACE-dependent, as shedding was not sig-
nificantly induced in the TACE-deficient M2 AP-TGF-
CHO cells, while being restored by expression of mouse
TACE in these cells (Figure 5B). Similar to ATP, A23187-
induced shedding was partially inhibited by BAPTA-AM
(Figure 5A). One explanation for the partial inhibition by
BAPTA-AM is the possibility that a local influx of extracel-
lular calcium may avoid BAPTA-AM chelation, thus allow-
ing for ATP- or A23187-dependent shedding. To test for a
role for extracellular calcium, we used the nonspecific che-
lator EGTA in aqueous solution to sequester extracellular
calcium before stimulation. EGTA strongly inhibited TGF-
shedding by both ATP and A23187 (Figure 5C). Despite a
high affinity for calcium, EGTA can also chelate other metal
ions such as zinc that could interfere with TACE activity. To
rule out this possibility, we used hydrogen peroxide as a
calcium-independent stimulator of TGF- shedding (Shao
and Nadel, 2005). Hydrogen peroxide stimulated TGF- shed-
ding, but was not sensitive to EGTA pretreatment (Figure 5D).
These results demonstrate that extracellular calcium is an im-
portant signaling component in TACE-mediated ATP-induced
TGF- shedding and indicate that hydrogen peroxide can stim-
ulate TGF- shedding independently of calcium.
Pathways involving the protein kinase C family and Src-
family nonreceptor tyrosine kinases have also been impli-
cated in regulating the shedding of a number of EGF family
members, including GPCR-induced shedding (Arribas and
Massagué, 1995; Izumi et al., 1998; Pierce et al., 2001; McCole
et al., 2002; Nagano et al., 2004; Stoeck et al., 2006). Involve-
ment of PKC proteins can be tested with the inhibitor bisin-
Figure 4. ATP-stimulated TGF- shedding requires calcium and
ROS. CHO AP-TGF- cells were serum-starved for 4 h and pre-
treated with vehicle (DMSO) or the following concentration of
inhibitors for 30 min: 50 M BAPTA-AM (BAP); 10 M PP2; 10 M
PP3; 20 nM BIM-I; 10 M SB202190 (SB2); 10 M SB203580 (SB3); 20
M PD98059 (PD); and 5 mM NAC. After stimulation with vehicle
or 100 M ATP for 5 min, media were collected and analyzed for
alkaline phosphatase (AP) activity. AP activity is presented relative
to the unstimulated control. *p  0.05 compared with control; #p 
0.05 compared with uninhibited stimulation. All others not signifi-
cant. Figure 5. Calcium regulates ATP-induced, TACE-dependent TGF-
shedding. (A) CHO AP-TGF- cells were pretreated with vehicle or 50
M BAPTA-AM for 30 min. Cells were then stimulated for 5 min with
vehicle, 100 M ATP, or 1 M A23187. (B) Mutant M2 CHO AP-TGF-
clones, which lack functional endogenous TACE, or TACE M2 CHO
AP-TGF- clones, which stably express mouse TACE (bottom panel),
were stimulated for 5 min with vehicle or 1 M A23187. (C) CHO
AP-TGF- cells were pretreated with water or 500 M EGTA for 30
min. Cells were then stimulated for 5 min with vehicle, 100 M ATP,
or 1 M A23187. (D) CHO AP-TGF- cells were pretreated with water
or 500 M EGTA for 30 min. Cells were then stimulated for 5 min with
vehicle, 1 M A23187 or 30 M hydrogen peroxide (HP). Media for all
experiments were collected and analyzed for alkaline phosphatase
(AP) activity. Results are an average of three separate experiments with
at least three replicates. AP activity is presented relative to the un-
stimulated control. *p  0.05 compared with control; #p  0.05 com-
pared with uninhibited stimulation.
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dolylmaleimide-1 (BIM-1), whereas Src family members can
be probed with the inhibitor PP2 and the nonfunctional
structural homolog PP3. As shown in Figure 4, PP2 had an
insignificant effect with results indistinguishable from PP3,
indicating no specific contribution of Src and related nonre-
ceptor tyrosine kinase pathways. Treatment with the broad
spectrum PKC inhibitor BIM-1 also did not significantly
inhibit ATP-stimulated TGF- shedding. MAPK pathways
have also been associated with growth factor shedding after
stress or other stimuli (Fan and Derynck, 1999; Gechtman et
al., 1999; Umata et al., 2001; Fischer et al., 2004; Zhuang and
Schnellmann, 2004). However, we observed no inhibition of
TGF- release when p38 MAPK signaling (SB202190;
SB203580) or ERK activity (PD98059) was blocked with in-
hibitors for each pathway (Figure 4). These results were
confirmed by RIA analysis in mouse EC-4 cells (data not
shown). To rule out toxicity of inhibitors as a trivial explanation
for our results, we tested each inhibitor’s effect on cell viability
at the concentration used in these experiments. We found that
cell numbers remained the same as control-treated cells for all
reagents (Supplemental Table S1). Moreover, these signaling
inhibitors did not interfere with the ability of the TGF- anti-
body to measure TGF- by RIA (Supplemental Figure S3A),
nor did they interfere with the ability to detect AP activity
(Supplemental Figure S3B), though BAPTA-AM increased the
level of AP activity in some experiments. Therefore, we have
established that these reagents have no effect on cell viability or
assay function, yet despite the demonstrated importance of
these pathways, they are not required for ATP-stimulated
TGF- shedding.
Recent studies of ADAM regulation, and specifically
TACE, have focused on the ability of ROS to act as signaling
intermediates. Our results indicate that hydrogen peroxide
could stimulate TGF- shedding (Figure 5D), consistent
with studies of TACE activation and shedding of both HB-
EGF and TGF- (Zhang et al., 2001; Frank and Eguchi, 2003;
Shao and Nadel, 2005). Cell-derived ROS have also been
found as signaling intermediates downstream of the angio-
tensin II receptor and P2Y purinergic receptors (Sauer et al.,
2001; Mifune et al., 2005; Pines et al., 2005); thus we hypoth-
esized that cellular ROS may also play a role in ATP-induced
TGF- shedding. We tested this by treating CHO AP-TGF-
cells with the ROS scavenger NAC. Shedding of TGF- was
dramatically reduced in the presence of NAC, pointing to a
significant role for ROS in the regulation of TGF- shedding
(Figures 4 and 6A). The importance of cell-derived ROS was
confirmed by testing endogenous TGF- shedding in mouse
fibroblasts, where NAC also significantly inhibited ATP-stim-
ulated shedding (Supplemental Figure S4A). To determine if
ROS-induced TGF- shedding was metalloprotease-depen-
dent, we used the inhibitor TAPI-2, which completely blocked
hydrogen peroxide–induced TGF- shedding (Figure 6B). The
importance of TACE as a specific metalloprotease was demon-
strated by the lack of shedding from M2-AP-TGF- cells and
the restoration of hydrogen peroxide–induced shedding with
the expression of mouse TACE (Figure 6C). Thus, ROS signal-
ing appears to be a key intermediate in TACE-mediated TGF-
shedding that is part of a conserved pathway following P2Y
receptor activation.
Several sources of ROS exist within nonphagocytic cells,
including the cytoplasmic NADPH oxidase, the mitochon-
drial electron transport chain, nitric oxide synthase, and
several other oxidases (Aslan and Freeman, 2002). In most
nonphagocytic cells the NADPH oxidase produces the ma-
jority of cytoplasmic superoxide, which is then rapidly dis-
mutated into hydrogen peroxide (Brandes and Kreuzer,
2005). Several reports present evidence of a role for the
NADPH oxidase in UV-induced (Singh et al., 2009) and
GPCR-induced transactivation of EGFR (Ushio-Fukai et al.,
1996; Lemjabbar et al., 2003; Zhang et al., 2004; Shao and
Nadel, 2005; Stoeck et al., 2006). To investigate a role for the
NADPH oxidase in TGF- shedding, we tested the effect of
apocynin, which blocks formation of the complete NADPH
oxidase complex, thus blocking ROS production by this
source. CHO AP-TGF- cells preincubated with 1 mM apo-
cynin and then stimulated with water or ATP showed no
effects on TGF- shedding (Figure 7A). This might be ex-
pected since CHO cells have been reported to lack p22phox,
a key component of the NADPH oxidase complex (Takeya et
al., 2003). To further confirm the inability of CHO cells to
produce NADPH oxidase-dependent ROS, we measured the
Figure 6. ROS mediate ATP-induced TGF- shedding. (A) CHO
AP-TGF- cells were pretreated with vehicle or 5 mM NAC for 30
min. Cells were then stimulated for 5 min with vehicle or 100 M
ATP. (B) CHO AP-TGF- cells were pretreated with vehicle or 20
M TAPI-2 for 30 min. Cells were then stimulated for 5 min with
vehicle, 100 M ATP, or 30 M hydrogen peroxide (HP). (C) Mutant
M2 CHO AP-TGF- clones, which lack functional endogenous
TACE, or TACE M2 CHO AP-TGF- clones, which stably express
mouse TACE (bottom panel), were stimulated for 5 min with vehicle
or 30 M HP. Media for all experiments were collected and ana-
lyzed for alkaline phosphatase activity. Results are an average of
three separate experiments with at least three replicates. AP activity is
presented relative to the unstimulated control. *p  0.05 compared
with control; #p  0.05 compared with uninhibited stimulation.
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production of superoxide from isolated membrane proteins
of stimulated cells. CHO cells and HL-60 cells, which are
human promyelocytic cells that can be stimulated by PMA
to form an active NADPH oxidase complex, were stimulated
with water, 100 M ATP, or 20 M PMA for 5 min. Mem-
brane proteins were isolated from these cells and used to
measure superoxide production through cytochrome C re-
duction. In CHO cells, neither ATP nor PMA treatment
produced any superoxide, confirming that these cells lack
the endogenous machinery to form an active NADPH oxi-
dase complex (Figure 7B). In contrast, in control HL-60 cells,
neither water nor ATP was able to stimulate superoxide
production, while PMA-treated cells showed a steady in-
crease over time (Figure 7C). Therefore the ROS involved in
ATP-stimulated TGF- shedding in CHO cells must come
from another source. We also tested the involvement of the
NADPH oxidase complex on endogenous shedding from
EC-4 mouse fibroblasts. In these cells, apocynin also had no
effect on ATP-stimulated TGF- shedding at any concentra-
tion tested (Supplemental Figure S4B), indicating an
NADPH-oxidase independent mechanism of ROS produc-
tion following P2Y receptor stimulation.
The electron transport chain of the mitochondrion is an-
other major source of cellular ROS. To determine if mito-
chondrially derived ROS contributes to regulation of TGF-
shedding, we examined two independent inhibitors of the
electron transport chain: rotenone, which inhibits transfer of
electrons from iron-sulfur centers to ubiquinone in complex
I, and myxothiazol, which inhibits transfer of electrons be-
tween cytochrome b and cytochrome c1 in complex III.
Treatment with myxothiazol resulted in a consistent, signif-
icant decrease in shedding compared with ATP alone (Fig-
ure 8A). The complex I inhibitor rotenone blocked the ma-
jority of ATP-stimulated TGF- shedding (Figure 8B). These
inhibitors were individually unable to inhibit shedding to
the same extent as the ROS scavenger NAC. However, when
Figure 7. ATP-induced TGF- shedding is independent of
NADPH oxidase activity. (A) CHO AP-TGF- cells were pretreated
with DMSO or 1 mM apocynin for 30 min. Cells were then stimu-
lated for 5 min with vehicle or 100 M ATP. Media were collected
and analyzed for alkaline phosphatase (AP) activity. Results are an
average of three separate experiments with at least three replicates.
AP activity is presented relative to the unstimulated control. Plasma
membrane proteins from stimulated CHO (B) and HL-60 (C) cells
incubated in cytochrome C reaction buffer were used to measure
superoxide production by way of cytochrome C reduction as mea-
sured by changes in absorbance at 550 nm in the presence and
absence of SOD at the indicated times. Results are an average of
three independent experiments. *p  0.05 compared with control.
Figure 8. Mitochondrially derived ROS are required for ATP-
induced TGF- shedding. (A) CHO AP-TGF- cells were pretreated
with DMSO or 1 M myxothiazol for 30 min. Cells were then
stimulated for 5 min with vehicle or 100 M ATP. (B) CHO AP-
TGF- cells were pretreated with DMSO or 25 M rotenone for 30
min. Cells were then stimulated for 5 min with vehicle or 100 M
ATP. (C) CHO AP-TGF- cells were pretreated with DMSO, 5 mM
NAC, or 1 M myxothiazol and 25 M rotenone for 30 min. Cells
were then stimulated for 5 min with vehicle or 100 M ATP. (D)
CHO cells were pretreated with vehicle or 1 M myxothiazol and 25
M rotenone for 30 min. During pretreatment, cells were also
loaded with 250 nM MitoTracker Red and treated as described in
Materials and Methods. Cells were stimulated with vehicle or 100 M
ATP. Boxes represent the 25th, 50th, and 75th quartiles and error
bars the minimum and maximum reading and are presented in this
manner to more fully display all the data points. These data repre-
sent three separate experiments of at least four replicates relative to
the unstimulated control. *p  0.03 compared with the unstimu-
lated control; †p  0.001 compared with the stimulated control. (E)
CHO AP-TGF- cells were serum-starved for 4 h and pretreated
with DMSO, 5 mM NAC, 1 M myxothiazol, 25 M rotenone, or 1
M myxothiazol and 25 M rotenone for 30 min. Cells were then
stimulated for 5 min with vehicle or 1 M A23187. Media for all
alkaline phosphatase (AP) assays were collected and analyzed for
AP activity. All assays are an average of three separate experiments
with at least three replicates and presented relative to the unstimu-
lated control samples. *p  0.05 compared with control; #p  0.05
compared with uninhibited stimulation.
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used in tandem, rotenone and myxothiazol reduced shed-
ding as effectively as NAC (Figure 8C). Confirming the
relevance of this pathway in endogenous ATP–stimulated
shedding of TGF-, rotenone and myxothiazol in combina-
tion also inhibited shedding to the same level as NAC in
mouse EC-4 cells (Supplemental Figure S4A). None of these
inhibitors had any effect on cell viability or AP enzyme
activity (Supplemental Table 1 and Supplemental Figure
3B), ruling out trivial effects on the assay system. These
results strongly suggest that ROS produced in combina-
tion from mitochondrial complex I and complex III are an
essential component of the regulatory pathway for GPCR-
induced TGF- shedding.
We therefore asked whether ATP stimulation increased
the levels of mitochondrial ROS, by directly measuring ROS
using the CM-H2XRos MitoTracker Red. This fluorescent
dye is specifically sequestered in mitochondria and remains
nonfluorescent until oxidized. Cells stimulated with ATP for
5 min displayed a significant, rapid increase in fluorescence
intensity over that of control cells (Figure 8D). This increase
in ROS-dependent fluorescence was inhibited by pretreat-
ment with the combination of mitochondrial inhibitors ro-
tenone and myxothiazol. Taken together, these results indi-
cate that ATP-stimulated signaling pathways can induce
production of ROS from mitochondrial oxidative com-
plexes, which is an essential step in regulating TACE-
dependent TGF- shedding.
Increases in calcium concentration due to ATP activation
of purinergic receptors occur rapidly through G-protein cou-
pling to calcium channels (Abbracchio et al., 2006). Calcium
is a known effector of mitochondrial function, including
increasing production of ROS (Brookes et al., 2004). This
suggests that calcium signaling could be an early step in
ATP activation of TACE-dependent shedding and could
occur upstream of mitochondrial ROS production. This is
supported by our results that show that calcium chelation by
EGTA was unable to inhibit hydrogen peroxide–dependent
TGF- shedding (Figure 5D). To test whether calcium-in-
duced TGF- shedding was dependent on mitochondrial
ROS we examined ROS inhibitor effects on A23187-stimu-
lated shedding. The ROS scavenger NAC partially inhibited
this shedding event (Figure 8E). Mitochondrial inhibitors
myxothiazol and rotenone individually and together also
partially inhibited A23187-induced shedding as did treat-
ment with both inhibitors. These results further support our
hypothesis that ATP-induced calcium mobilization contrib-
utes to increases in mitochondrial ROS and activation of
TACE-dependent TGF- shedding.
DISCUSSION
Transactivation of EGFR via GPCR signaling has emerged as
an important event for signal integration and amplification
in many biologically essential processes and typically re-
quires a metalloprotease-mediated growth factor cleavage
event (Blobel, 2005; Ohtsu et al., 2006). This study examines
a ROS-dependent transactivation pathway from the P2Y
family of GPCRs that utilizes TACE/ADAM17 metallopro-
tease activity to cleave TGF-, followed by activation of
EGFR. Our goal was to begin to elucidate the signaling
events leading to TACE-mediated growth factor cleavage
after stimulation with GPCR agonists. We report here the
first observation of mitochondrially produced ROS as a crit-
ical step in regulated growth factor proteolysis.
Extracellular nucleotides such as ATP are released from
many cell types in response to stress and mechanical or
biochemical stimulation (Abbracchio et al., 2006) and can
function as a paracrine signal for the P2Y family of puriner-
gic receptors. In this study we identified a P2Y-dependent
pathway leading to TGF- shedding and transactivation of
EGFR. Prominent expression of P2Y2 in mouse cells, along
with the lack of detectable P2Y4 expression in CHO cells,
suggests a favored role for the P2Y2 subtype in this transac-
tivation pathway. P2Y2 receptors have been previously
linked to EGFR transactivation in PC12 cells and rat fibro-
blasts (Soltoff, 1998; Soltoff et al., 1998), consistent with the
ability of these receptors to stimulate proliferation of cells
such as epidermal keratinocytes (Greig et al., 2003) and
smooth muscle cells (Wilden et al., 1998). P2Y2 receptors are
also important for regulating ion channel function in epithe-
lial cells (Abbracchio et al., 2006). Activation of P2Y2 can
promote mucin release in airway cells, an event that has also
been tied to TACE-dependent TGF- shedding and EGFR
transactivation (Yerxa et al., 2002; Shao et al., 2003). Extracel-
lular release of ATP is also a hallmark of epithelial wound
healing. In vitro wounding experiments utilize EGFR trans-
activation by purinergic receptors to initiate migration and
healing of epithelial cells (Boucher et al., 2007; Yin et al.,
2007). Thus, elucidation of the mechanisms responsible for
regulating EGFR transactivation pathways could have im-
portant physiological and therapeutic implications.
A recent study showed that ATP stimulation through
P2Y2 receptors led to both ADAM10 and TACE metallopro-
tease activity toward amyloid precursor protein in astrocy-
toma cells (Camden et al., 2005). Here, we show that ATP
stimulated endogenous TACE-dependent TGF- shedding
in mouse fibroblasts and AP-TGF- shedding in CHO cells,
consistent with previous evidence for TACE as the major
constitutive and PMA-stimulated TGF- sheddase (Peschon
et al., 1998; Hinkle et al., 2004; Sahin et al., 2004; Horiuchi et
al., 2007). A variety of studies have implicated roles for other
ADAM proteases in TGF- processing under specific condi-
tions (Merlos-Suarez et al., 2001; Hinkle et al., 2003; Schafer et
al., 2004b; Horiuchi et al., 2007), including for ADAM10 in
the absence of TACE (Le Gall et al., 2009). Although
ADAM10 activity may explain the minor residual shedding
in both TACE-deficient EC-2 mouse and CHO cells, the
significant loss of TGF- release and of EGFR transactivation
associated with TACE deficiency, or knockdown by siRNA,
together with restoration of shedding by TACE in EC-2 and
CHO M2 cells, indicates that TACE is the predominant
TGF- sheddase in this model.
There is a high degree of correlation between ATP-depen-
dent TGF- shedding and EGFR transactivation in the
mouse fibroblast system that we tested. However, this does
not exclude other EGFR ligands from involvement in ATP-
induced receptor activation in this system. Other transacti-
vation models have shown TACE-dependent cleavage of AR
and HB-EGF to be important for EGFR phosphorylation as
well (Hart et al., 2004; Schafer et al., 2004a). It is therefore
possible that in the system we tested, additional EGF family
members are also shed in response to ATP stimulation and
this may contribute to the transactivation that we observed.
In this study, we undertook a further examination of the
signaling pathways leading to TACE activity. ROS have
recently gained attention as second messengers in GPCR
signaling pathways (Forman et al., 2002). P2Y family recep-
tors have been specifically linked to ROS production in
eosinophils and prostate tumor cells (Ferrari et al., 2000;
Sauer et al., 2001). Cellular ROS have also been implicated in
EGFR transactivation initiated via other GPCRs (Wang et al.,
2000; Zhang et al., 2004; Stoeck et al., 2006). We used hydro-
gen peroxide and the ROS scavenger NAC to establish a
critical role for ROS in P2Y receptor-dependent TGF- shed-
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ding. These observations are also consistent with other re-
ports that exogenous hydrogen peroxide can stimulate the
shedding of TGF- and other EGF family members such as
HB-EGF, AR, and betacellulin (Lemjabbar et al., 2003; Fischer
et al., 2004; Kim et al., 2005; Shao and Nadel, 2005; Stoeck
et al., 2006).
The cytoplasmic NADPH oxidase complex has been im-
plicated as the main source of cellular ROS in a number of
EGFR transactivation pathways. A role for NADPH oxidase-
derived ROS has been reported for GPCR agonists ATP,
angiotensin II, phenylephrine, endothelin-1, and tobacco
smoke (Ushio-Fukai et al., 2001; Lemjabbar et al., 2003;
Schafer et al., 2004a; Zhang et al., 2004; Chen et al., 2006;
Stoeck et al., 2006; Boots et al., 2009), for UV-induced signal-
ing (Singh et al., 2009), and for the global activator of shed-
ding, PMA (Shao and Nadel, 2005). In addition to inhibitor
studies, a role for NADPH oxidase-derived ROS in EGFR
transactivation was identified using induced phosphoryla-
tion of p47 (Pietri et al., 2005), a key subunit of NADPH
oxidase, and also the more stringent knockdown of the
NADPH oxidase subunits Duox1 or p47phox (Shao and
Nadel, 2005; Chen et al., 2006). ATP signaling through puri-
nergic receptors has also been demonstrated to activate
Duox1/Nox in airway epithelial cells (Wesley et al., 2007;
Boots et al., 2009). We investigated the involvement of the
NADPH oxidase complex in our system using the inhibitor
apocynin, which directly blocks complex formation. We ob-
served that at apocynin concentrations ranging from 30 M up
to 1 mM, ATP-induced TGF- shedding was unaffected. Fur-
thermore, we found no evidence of an active NADPH oxidase
complex in CHO cells, supporting previous findings in the
literature (Takeya et al., 2003). These results rule out the
NADPH oxidase complex as a component of this pathway.
To further examine the source of ROS for regulation of
P2Y-dependent TGF- shedding, we used specific inhibitors
of complex I and complex III of the mitochondrial electron
transport chain to gauge the contributions of mitochondrial
ROS. The inhibitors myxothiazol and rotenone partially de-
creased shedding when used individually, but when used
together inhibited fully, as did the general ROS scavenger
NAC, indicating that the functional ROS generated in this
pathway can be entirely attributed to mitochondrial sources.
In mouse cells, NAC and the combination of rotenone and
myxothiazol also inhibited ATP-stimulated shedding to the
same extent, indicating the requirement for mitochondrial
ROS in this cell type as well. Mitochondrial ROS have been
implicated in aging and cell fate, cell responses to hypoxia
and many aspects of cardiovascular biology (Zhang and
Gutterman, 2007). Hydrogen peroxide–induced EGFR acti-
vation can depend on mitochondrial ROS (Chen et al., 2004).
Induction of mitochondrial ROS as a downstream signal of
EGFR, estrogen, and NMDA receptors reveals a role for
mitochondrial ROS as signaling messengers for important
cellular receptors (Krieg et al., 2004; Felty et al., 2005; Hao et
al., 2006; Lee et al., 2006; Duan et al., 2007). Here, we present
evidence for mitochondrial ROS as a signaling intermediate
for regulation of P2Y-induced, TACE-dependent growth fac-
tor shedding. This novel observation of mitochondrial ROS
in regulating shedding reveals another possible mechanism
that cells may use to specify certain pathways for respond-
ing to various stimuli.
ROS-mediated TACE-dependent shedding may also in-
volve other signaling molecules that have been implicated in
EGFR transactivation. Increases in intracellular calcium con-
centrations are a well-characterized result of GPCR activa-
tion (Werry et al., 2003), and this extracellular calcium influx
can subsequently stimulate ROS-induced signaling (Sauer et
al., 2001; Ushio-Fukai et al., 2001; Mifune et al., 2005; Pines et
al., 2005; Watanabe et al., 2006). In our CHO AP-TGF- cells,
TACE-dependent TGF- shedding was stimulated by the
ionophore A23187, and inhibited by calcium chelation with
BAPTA-AM and EGTA. Calcium chelation had little to no
effect on hydrogen peroxide–stimulated shedding, suggest-
ing that the calcium signal preceded ROS production in our
system. This was further supported by the blocking of
A23187-induced TGF- shedding with the mitochondrial
inhibitors used to block ATP-induced shedding. In contrast
to ATP, A23187-induced shedding was only partially inhib-
ited by the ROS scavenger NAC and the mitochondrial
inhibitors myxothiazol and rotenone. This may be explained
by the previous observation in CHO-BQ1 cells that A23187
induced higher levels of intracellular calcium than ATP
treatment (Marcet et al., 2003). The calcium ionophore-in-
duced residual shedding seen in M2 cells and in NAC-
treated wild-type CHO cells may indicate a ROS- and
TACE- independent shedding event involving ADAM10
such as that shown in mouse Tace/ fibroblasts (Horiuchi et
al., 2007; Le Gall et al., 2009). Calcium signaling is a well-
known effector of mitochondrial function and mitochondrial
ROS production (Brookes et al., 2004). Although the mecha-
nism is still under investigation, the observations here dem-
onstrate a role for calcium signaling upstream of required
mitochondrial ROS.
PKC has been widely implicated in regulation of ectodo-
main shedding based on the well-established ability of phor-
bol esters to stimulate TACE-dependent TGF- shedding
(Fan et al., 2003; Hinkle et al., 2004; Sahin et al., 2004; Horiu-
chi et al., 2007). Previous reports implicated PKC isoforms in
TACE phosphorylation and activation (Alfa Cisse et al., 2008;
Reddy et al., 2008). In our study, treatment of cells with the
broad spectrum PKC inhibitor BIM-1 (GF109203X) did not
affect ATP-stimulated TGF- release. Src family kinases
have also been implicated in several GPCR-mediated trans-
activation cascades upstream of growth factor shedding,
including the direct association of Src with TACE, that led to
TACE phosphorylation and increased shedding of amphi-
regulin (Zhang et al., 2006) or with P2Y2 receptors via SH3
motifs (Liu et al., 2004). There is also evidence suggesting
ROS may modulate Src function in transactivation schemes
(Ushio-Fukai et al., 2001; Zhuang and Schnellmann, 2004). In
contrast, Camden et al. (2005) demonstrated Src-indepen-
dent activation of TACE and ADAM10 after ATP stimulation.
We also show that ATP-dependent activation of TGF- shed-
ding is independent of the PP2-sensitive Src family members
Src, Fyn, Hck, and Lck. Likewise ERK/MAPK pathways have
been implicated in activation of TACE-dependent growth fac-
tor shedding by serum, stress, VEGF-A, ATP, and other stimuli
(Fan and Derynck, 1999; Gechtman et al., 1999; Umata et al.,
2001; Gschwind et al., 2003; Fischer et al., 2004; Zhuang and
Schnellmann, 2004; Swendeman et al., 2008; Yin and Yu, 2009)
possibly by phosphorylation of the cytoplasmic domain of
TACE (Soond et al., 2005). We found no evidence for ERK/
MAPK signals playing a regulatory role in TGF- shedding in
our model. This further underscores the selective use of avail-
able regulatory pathways for particular substrates or physio-
logical events.
The mechanism of TACE activation remains unclear.
However, the large number of agonists and substrates uti-
lizing ROS strongly suggest ROS are common regulators of
TACE activity. ROS may cause direct modifications of TACE
in response to stimulation. The prodomain of TACE can
bind to a cysteine in the metalloprotease active site to inhibit
cleavage (Seals and Courtneidge, 2003; Li et al., 2008). ROS
have been shown to oxidize the cysteine thiol group thereby
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relieving the inhibition of the metalloprotease activity
(Zhang et al., 2001). TACE also contains an extracellular
cysteine-rich domain including two cysteine residues previ-
ously shown to be important in TACE functionality (Li and
Fan, 2004) and specifically for hydrogen peroxide–induced,
TACE-dependent L-selectin shedding in neutrophils (Wang
et al., 2009). These could be potential targets for ROS-depen-
dent modifications. ROS may also indirectly activate TACE
by alteration and modification of effector proteins. Demon-
strated phosphorylation of TACE by interaction with ERK
(Soond et al., 2005), one of several PKC isoforms (Roghani et
al., 1999; Alfa Cisse et al., 2008; Reddy et al., 2008), or with
phosphoinositide-dependent kinase-1 (Zhang et al., 2006)
could all be regulated by ROS modifications of these kinases
or by the negative regulation of phosphatases. Modifications
by ROS on scaffold proteins that are involved in substrate
selection or presentation is another potential regulatory
mechanism. The noncatalytic Eve-1 protein is thought to
regulate EGF-like growth factor shedding in response to
PMA (Tanaka et al., 2004), whereas NRDc enhances shed-
ding of the TACE substrates HB-EGF (Nishi et al., 2006) and
TNF- (Hiraoka et al., 2008). Most recently a tripartite
complex between DLG1/SAP97, TACE and proTGF-
was identified, where both knockdown and overexpres-
sion of DLG1 led to inhibition of PMA-induced TGF- shed-
ding (Surena et al., 2009). Lastly, TACE activity regulated by
localization in membrane subdomains (Tellier et al., 2006)
could be affected by ROS modifications of lipids and mem-
brane components (Zmijewski et al., 2005). By altering the
membrane and creating or abolishing subdomains, protein
localization complexes and enzyme–substrate interactions
could all be influenced. Thus, the ability of ROS to freely
diffuse throughout the cell and their high reactivity with
proteins and membranes allow many different possible reg-
ulatory mechanisms.
In summary, we present evidence for the first time of
mitochondrially derived ROS regulation of ATP-stimulated,
TACE-dependent shedding of TGF-. Because TGF- sig-
nals act exclusively through EGFR, this may represent one
mechanism to maintain the specificity of biochemical signal-
ing pathways. A recent report examining the existence of
multiple transactivating mechanisms in a single cell high-
lights the need for specific pathways for different transacti-
vation schemes (Rodland et al., 2008). The discovery of mi-
tochondrial ROS as a novel, key regulatory intermediate in
TACE-dependent shedding of TGF- reveals an additional
mechanism for regulating the complexity of signaling
through common cellular pathways.
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